theMednet - If AYA patients with AML are MRD negative after 1 cycle of chemotherapy, and high risk for relapse, should they receive additional cycles of chemotherapy or proceed directly to transplant?

Topics: Pediatric Oncology • Medical Oncology • Leukemia • MD Anderson • AML • AYA • AYA Tumor Board

If AYA patients with AML are MRD negative after 1 cycle of chemotherapy, and high risk for relapse, should they receive additional cycles of chemotherapy or proceed directly to transplant?